Home infusion: Bioscrip to buy HomeChoice Partners
EDEN PRAIRIE, Minn. – BioScrip, a specialty pharmacy services provider based here, will acquire HomeChoice Partners for $70 million, in a move designed to strengthen its home infusion services, according to multiple reports. HomeChoice is an alternate-site infusion pharmacy services provider. The acquisition follows BioScrip’s July purchase of InfuScience, also an alternate-site provider of home infusion services. Revenue for home infusion services have spiked 39.5% in the last reported quarter, according to Zacks, an investment research website. BioScrip expects to close the deal in the first quarter of 2013.